A detailed history of Deka Bank Deutsche Girozentrale transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 1,747,168 shares of EW stock, worth $118 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
1,747,168
Previous 1,682,555 3.84%
Holding current value
$118 Million
Previous $157 Million 26.38%
% of portfolio
0.21%
Previous 0.28%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$59.7 - $93.78 $3.86 Million - $6.06 Million
64,613 Added 3.84%
1,747,168 $116 Million
Q2 2024

Aug 08, 2024

SELL
$84.3 - $94.31 $23.5 Million - $26.3 Million
-278,654 Reduced 14.21%
1,682,555 $157 Million
Q1 2024

Apr 24, 2024

SELL
$72.54 - $95.56 $22.9 Million - $30.1 Million
-315,362 Reduced 13.85%
1,961,209 $188 Million
Q4 2023

Jan 24, 2024

BUY
$61.71 - $77.76 $47.4 Million - $59.7 Million
767,997 Added 50.91%
2,276,571 $174 Million
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $6.9 Million - $9.29 Million
99,535 Added 7.06%
1,508,574 $105 Million
Q2 2023

Jul 25, 2023

BUY
$81.41 - $94.33 $9.25 Million - $10.7 Million
113,614 Added 8.77%
1,409,039 $131 Million
Q1 2023

Apr 24, 2023

SELL
$74.26 - $84.51 $12.9 Million - $14.6 Million
-173,159 Reduced 11.79%
1,295,425 $106 Million
Q4 2022

Feb 01, 2023

BUY
$68.3 - $87.44 $69 Million - $88.3 Million
1,010,261 Added 220.43%
1,468,584 $110 Million
Q3 2022

Nov 02, 2022

SELL
$82.37 - $107.29 $2.13 Million - $2.78 Million
-25,889 Reduced 5.35%
458,323 $38.1 Million
Q2 2022

Aug 03, 2022

BUY
$86.5 - $128.27 $7.41 Million - $11 Million
85,681 Added 21.5%
484,212 $45.8 Million
Q1 2022

Apr 28, 2022

BUY
$101.96 - $128.34 $1.88 Million - $2.36 Million
18,392 Added 4.84%
398,531 $47.2 Million
Q4 2021

Feb 02, 2022

BUY
$106.37 - $130.68 $5.5 Million - $6.76 Million
51,697 Added 15.74%
380,139 $49.8 Million
Q3 2021

Oct 22, 2021

SELL
$102.91 - $122.75 $5.56 Million - $6.64 Million
-54,056 Reduced 14.13%
328,442 $37.4 Million
Q2 2021

Aug 05, 2021

BUY
$83.84 - $104.76 $440,411 - $550,304
5,253 Added 1.39%
382,498 $39.3 Million
Q1 2021

Apr 28, 2021

SELL
$78.68 - $90.67 $3.51 Million - $4.04 Million
-44,600 Reduced 10.57%
377,245 $31 Million
Q4 2020

Mar 12, 2021

BUY
$71.69 - $91.23 $4.13 Million - $5.26 Million
57,665 Added 15.83%
421,845 $38.1 Million
Q3 2020

Oct 29, 2020

BUY
$67.19 - $87.44 $6.59 Million - $8.58 Million
98,135 Added 36.89%
364,180 $28.2 Million
Q2 2020

Aug 04, 2020

BUY
$57.54 - $76.95 $10.3 Million - $13.8 Million
179,756 Added 208.32%
266,045 $18.1 Million
Q1 2020

May 14, 2020

BUY
$52.41 - $81.0 $2.28 Million - $3.52 Million
43,447 Added 101.41%
86,289 $17 Million
Q4 2019

Feb 04, 2020

SELL
$71.7 - $82.09 $823,402 - $942,721
-11,484 Reduced 21.14%
42,842 $10.1 Million
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $513,511 - $629,312
-8,343 Reduced 13.31%
54,326 $11.9 Million
Q2 2019

Aug 01, 2019

BUY
$55.74 - $64.41 $17,836 - $20,611
320 Added 0.51%
62,669 $11.7 Million
Q1 2019

May 10, 2019

BUY
$47.89 - $64.05 $707,814 - $946,659
14,780 Added 31.07%
62,349 $9.09 Million
Q4 2018

Feb 12, 2019

SELL
$46.41 - $56.94 $685,939 - $841,573
-14,780 Reduced 23.71%
47,569 $7.24 Million
Q3 2018

Nov 09, 2018

BUY
$45.7 - $58.03 $1.3 Million - $1.65 Million
28,355 Added 83.41%
62,349 $0
Q2 2018

Aug 14, 2018

SELL
$42.45 - $51.3 $545,270 - $658,948
-12,845 Reduced 27.42%
33,994 $5.07 Million
Q1 2018

May 03, 2018

SELL
$37.19 - $47.45 $4.33 Million - $5.53 Million
-116,511 Reduced 71.33%
46,839 $6.56 Million
Q3 2017

Nov 06, 2017

BUY
$36.29 - $38.83 $5.93 Million - $6.34 Million
163,350
163,350 $19 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.